id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-342324-it6zcyht	Dhaliwal, Ruban	Letter to the Editor: “Our Response to COVID-19 as Endocrinologists and Diabetologists”	2020-05-08		.txt	text/plain	684	56	52	Thus, there is a need for close monitoring of serum calcium levels in symptomatic COVID patients, and adherence with calcitriol and calcium supplements as prescribed and follow sick-day guidelines (4). Second area of concern is the potential for interruption of parenteral treatments in patients with osteoporosis during this pandemic, many of whom are in the high-risk group for COVID-19 infection because of advanced age and/or comorbidities. While administration of intravenous zoledronic acid can be delayed for a few months to a year, such time-lapse latitude does not apply to subcutaneous denosumab because of the potential for the so-called "rebound fractures" (5), although there is no consensus on this complication (6) . Finally, timing the transition of treatment from anabolic (teriparatide, abaloparatide, romosozumab) to injectable antiresorptive therapy (zoledronic acid, denosumab) during a pandemic is also important. Letter to the Editor: Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation	./cache/cord-342324-it6zcyht.txt	./txt/cord-342324-it6zcyht.txt